Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 29.96
+0.10 (0.33%)
Nov 10, 2026, 4:08 PM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 11.02 billion as of November 9, 2026. It is the 8,200th most valuable company in the world and the 409th biggest in Hong Kong. Its market cap has decreased by 51.95% in one year.
Market Cap
11.02B
Enterprise Value
11.26B
Revenue
741.90M
Global Rank
Country Rank
#409 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 11.02B, an increase of 45.20%. That is a compound annual growth rate of 5.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 11.02B | -42.71% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Metis TechBio | 13.38B |
| Duality Biotherapeutics | 9.67B |
| Everest Medicines | 9.59B |
| HBM Holdings | 9.15B |
| GenFleet Therapeutics (Shanghai) | 8.93B |
| CStone Pharmaceuticals | 8.69B |
| Shaanxi Micot Pharmaceutical Technology | 7.94B |
| Nanjing Leads Biolabs | 7.60B |